Variant report
Variant | esv1831308 |
---|---|
Chromosome Location | chr8:51029371-51038255 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1903311 | chr8:51029371-51029372 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs554814729 | chr8:51029372-51029373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573428294 | chr8:51029383-51029384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs117870240 | chr8:51029465-51029466 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551510807 | chr8:51029530-51029531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569997042 | chr8:51029537-51029538 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565270062 | chr8:51029555-51029556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs117600679 | chr8:51029573-51029574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543779583 | chr8:51029596-51029597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182876853 | chr8:51029602-51029603 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs16914298 | chr8:51029654-51029655 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs529717846 | chr8:51029714-51029715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537558149 | chr8:51029771-51029772 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566546290 | chr8:51029773-51029774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527523448 | chr8:51029788-51029789 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs16914299 | chr8:51029794-51029795 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs570730567 | chr8:51029799-51029800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538153259 | chr8:51029821-51029822 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368474053 | chr8:51029872-51029873 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557351264 | chr8:51029896-51029897 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569278244 | chr8:51029923-51029924 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536342761 | chr8:51029927-51029928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187513294 | chr8:51029935-51029936 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs17760044 | chr8:51029983-51029984 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs371906680 | chr8:51029994-51029995 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116656914 | chr8:51030005-51030006 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558750287 | chr8:51030099-51030100 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569868573 | chr8:51030103-51030104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187764446 | chr8:51030121-51030122 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs147631733 | chr8:51030161-51030162 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544516377 | chr8:51030162-51030163 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192391504 | chr8:51030177-51030178 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142256774 | chr8:51030230-51030231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs541552468 | chr8:51030251-51030252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568497066 | chr8:51030252-51030253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527414544 | chr8:51030284-51030285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535695658 | chr8:51030288-51030289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552364461 | chr8:51030296-51030297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200331849 | chr8:51030301-51030302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564280404 | chr8:51030319-51030320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150200083 | chr8:51030337-51030338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs374887582 | chr8:51030384-51030385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549180344 | chr8:51030468-51030469 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550146474 | chr8:51030475-51030476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569148489 | chr8:51030493-51030494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs16914302 | chr8:51030517-51030518 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs548370023 | chr8:51030568-51030569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs183928415 | chr8:51030599-51030600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs114044957 | chr8:51030603-51030604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs56194053 | chr8:51030626-51030627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51018400-51039600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
2 | chr8:51028600-51030600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr8:51029400-51030200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr8:51030200-51031000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr8:51031000-51031200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr8:51031000-51031600 | Enhancers | Osteobl | bone |
7 | chr8:51031400-51034800 | Weak transcription | Brain Germinal Matrix | brain |
8 | chr8:51031600-51038800 | Weak transcription | Osteobl | bone |
9 | chr8:51032200-51046600 | Weak transcription | Fetal Brain Male | brain |
10 | chr8:51034600-51035200 | Enhancers | H1 Cell Line | embryonic stem cell |
11 | chr8:51034600-51035200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
12 | chr8:51034600-51038200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr8:51034800-51035200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr8:51034800-51037800 | Enhancers | Brain Germinal Matrix | brain |
15 | chr8:51035000-51035600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr8:51037400-51039000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
17 | chr8:51037800-51046800 | Weak transcription | Brain Germinal Matrix | brain |
18 | chr8:51038000-51047600 | Weak transcription | Right Atrium | heart |
19 | chr8:51038200-51038600 | Enhancers | Spleen | Spleen |
20 | chr8:51038200-51038800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
21 | chr8:51038200-51038800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
22 | chr8:51038200-51040400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |